|
|
||||||||
Pleura Laboratory - Pulmonary Division, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
CORRESPONDENCE: E. Marchi, R. Lucia B. Passarin, 590 - Ap 42, 13.216-351, Jundiaí, São Paulo, Brazil. Fax: 55 1145221775. E-mail: evmarchi{at}uol.com.br
Keywords: Inflammatory mediators, pleural effusions, pleurodesis
Received: March 16, 2006
Accepted July 7, 2006
Intrapleural instillation of talc is used to produce pleurodesis in cases of recurrent malignant pleural effusions. The mechanisms by which pleurodesis is produced remain unknown but may involve either injury or activation of the mesothelium. The aim of the current study was to assess the inflammatory response of pleural mesothelial cells to talc in an experimental model in rabbits.
A group of 10 rabbits were injected intrapleurally with talc (200 mg·kg-1) and undiluted pleural fluid was collected after 6, 24 or 48 h for measurement of interleukin (IL)-8, vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-ß1. Samples of pleura were studied to assess the inflammatory infiltrate and mesothelial cell viability.
The pleural fluid IL-8 concentration peaked at 6 h, whereas VEGF and TGF-ß1 concentrations increased steadily over 48 h. Immunohistochemistry for cytokeratin showed a preserved layer of mesothelial cells despite the intense inflammatory pleural reaction.
In conclusion, it is proposed that the mesothelial cell, although injured by the talc, may actively mediate the primary inflammatory pleural response in talc-induced pleurodesis.
This article has been cited by other articles:
![]() |
V. Steger, U. Mika, H. Toomes, T. Walker, C. Engel, T. Kyriss, G. Ziemer, and G. Friedel Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses Ann. Thorac. Surg., June 1, 2007; 83(6): 1940 - 1945. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |